Agios Pharma (AGIO) Reports Q2 Loss of $1.47/Share
Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.47), versus ($0.85) reported last year. Revenue for the quarter came in at $6.98 million, versus $13.22 million reported last year.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
